Brazil's vaccine program can still succeed, despite Bolsonaro's politics

While Brazilian President Jair Bolsonaro's handling of the health crisis stands out as one of the worst among key political leaders around the world. is his response the main reason that Brazil isn't further along in its vaccination rollout, as Vanessa Barbara argues in an opinion piece for The New York Times? Ian Bremmer and Eurasia Group analysts Chris Garman and Marcelo Alvarenga take out the Red Pen to explain why the causes for delay are much more nuanced and in fact, Brazil has many advantages it can use to make its vaccine program a success.

Today we're focusing on an op-ed recently published in The New York Times, of all places, from contributing opinion writer Vanessa Barbara. She writes regularly about politics and life in Brazil, and that's what this piece is about. Specifically, vaccine rollout and why, in her opinion, it's been a big mess for Brazil and for President Jair Bolsonaro.

Now, without a doubt, Brazil has been one of the hardest hit countries in the world with this pandemic. More than a quarter-million deaths to date. Life getting worse right now, not better in Brazil. The most in the world, deaths, after the United States. Some 80% of all ICU beds are right now, filled at capacity in a majority of Brazil's states. And I have been highly critical of Bolsonaro's response overall, inflammatory comments, blatant disregard for public health protocols, his overt politicization of the crisis, one of the worst things you can possibly do. And just this week, a year into the pandemic, he yet again slammed the use of face masks. All horrible stuff. That kind of behavior definitely helped to create a bigger disaster in Brazil. I'd say the same by the way for Donald Trump in the United States and Mexico's President Lopez Obrador, keeping score.

But Barbara argues that Brazil, with its robust universal healthcare system and long history of successful immunization programs, should have been in a much better place to handle vaccine production and distribution in this pandemic, and lays the blame squarely at Bolsonaro's feet.

We think it's actually more nuanced than that, and that the vaccine story in Brazil isn't nearly as bad as this article would have you believe.

So, let's get out the Red Pen.

First, Barbara writes that Brazil's vaccine rollout "has been painfully slow, inconsistent and marred by shortages," and that the vaccination campaign's "current rate will take more than four years to complete."

Let's take a step back. Rollout in Brazil has been slower than in the United States, the United Kingdom or Israel, to be sure, the best in the world. But compared to other emerging markets like Argentina, Mexico, even Russia, it's doing quite well. In fact, with the exception of Chile, Brazil has the highest per capita vaccination rate in Latin America right now. She also faults Bolsonaro for not beginning the vaccination campaign until mid-January, weeks after some other nations started. That's not fair. There wasn't a vaccine approved for use in Brazil until January 17th, the day before shots started going into arms in that country. I'd also remind you the European Union, hell of a lot wealthier than Brazil, has struggled with its own delays in getting vaccine approved for emergency use.

"Brazil's vaccine rollout has been painfully slow, inconsistent and marred by shortages."  Brazil is slow compared to the US, UK, and Israel,. But compared to other emerging markets, it's doing pretty well.

Next, let's look at Barbara's point that Brazil "has a distinguished track record of vaccinations and disease control" which makes this particular rollout all the more upsetting.

Thankfully Brazil's experience at large-scale immunization campaigns and the infrastructure of its public health system haven't been washed away by President Bolsonaro's missteps. It actually means that Brazil is now in a position to ramp up production and distribution, taking advantage of that existing health care system. Brazil has 38,000 permanent vaccination stations and that will be expanded for coronavirus response. Fiocruz and the Butantan Institute, the main local providers of Covid-19 vaccines, are also the main suppliers of regular vaccines for the country's National Immunization Program, which just builds on any already existing network ranging from production to distribution.

"...the country has a distinguished track record of vaccinations and disease control." It's time - Brazil is in a better position than most. It also has significant domestic production capacity.

Now to that point on manufacturing: Barbara writes that "Brazil is now gradually expanding local production…But everything is happening in slow motion."

The beginning of Brazil's rollout did suffer from disruptions, and some of it falls squarely on mistakes and lack of planning on the part of Bolsonaro's administration. The administration was slow to secure multiple suppliers of the vaccine, hasn't yet struck an agreement with Pfizer. But delays in the ability to secure supply and delays in exports of active ingredients for local production of vaccines was not in any way particular to Brazil. The outlook for local production right now has improved considerably as supplies arrive for both Covishield (that's the Oxford-AstraZeneca vaccine) and the Chinese vaccine Coronavac.

"The federal government...focused on a single manufacturer, AstraZeneca." The beginning of Brazil's rollout did suffer from disruptions of the Covishield vaccine. But it is important to remember that rollout in the European Union hasn't particularly gone well, either.

All of these things put Brazil in a far better position than many of its peers globally. So, did Bolsonaro mess up and play politics with the pandemic in general? Yes, absolutely. Does that mean the hopes of a successful vaccine program in Brazil are dashed moving forward, and it is looking worse than its peers? Nope, not at all. And it's nice to be able to say something positive when so many other things are going badly in the country.

That's your Red Pen for this week. There's light at the end of the tunnel in Brazil and globally, but for now continue to stay safe and avoid people.

Demography is destiny. That ominous-sounding pronouncement, credited to French philosopher Auguste Comte, is today taken to mean that a nation's fate depends on the youthfulness of its population. For a poor country to become rich, it needs lots of young people ready to work, to support those too old or too young to work, and to pay taxes. This is called the "demographic dividend."

That's an important part of China's success story. Over the past 40 years, more than one billion people have emerged from poverty in China. Waves of young people surged from the countryside into cities to work in factories. The state invested in education, and wages helped young workers, and then their children, go to school. The state also began a drive to develop the technologies of the future, by any means necessary. In China, once dirt-poor, hundreds of millions have created a middle class.

More Show less

Do we spend too much time thinking about our own carbon footprints and not enough time thinking about bigger factors? Climate journalist Elizabeth Kolbert acknowledges it's necessary for individuals to make changes in the way they live, but that isn't the number one priority.

"What would you do to try to move this battleship in a new direction? It requires public policy levers. And it requires … some pretty serious legislation." Ian Bremmer spoke with Kolbert, an award-winning journalist and author and staff writer at The New Yorker, on a new episode of GZERO World, airing on US public television.

Watch the episode: Can We Fix the Planet the Same Way We Broke It?

Not everyone thinks that President Biden's decision to pull all US troops out of Afghanistan by 9/11/21 is a good idea. Conservative Congressman Mike Waltz (R-FL), a combat-decorated Green Beret with multiple tours in Afghanistan, thinks that the US still needs to maintain a small presence in the country to avoid incurring "massive risks." In a spirited discussion with Ian Bremmer on GZERO World, Waltz, who served as counterterrorism advisor in the George W. Bush administration, argues, "The next 9/11, the next Pulse Night Club, which is right on the edge of my congressional district, the next San Bernardino, that's now on Biden's watch. He owns it with this decision." Their conversation is featured in the upcoming episode of GZERO World, which airs on US public television starting Friday, April 23. Check local listings.

Vaccines are the best hope to end the COVID-19 pandemic. But rich countries are hogging most of the doses, with more than 83 percent of shots administered to date having gone to residents in high- and upper-middle-income countries. Most poor countries will have to wait years to achieve widespread vaccination, according to one study.

To address this inequity some stakeholders are pushing hard for waivers to intellectual-property (IP) rights through World Trade Organization trade rules so that manufacturers in poorer countries can make their own vaccines locally. India and South Africa have been leading the charge, which would essentially mean that deep-pocketed pharma companies like New York-based Pfizer, for instance, would have to hand over the keys to the kingdom, allowing local companies in New Delhi and Johannesberg to make generic versions of their vaccines.

Unsurprisingly, the debate has gotten fiery, with passionate arguments emerging both for and against.

More Show less

Carl Bildt, former Prime Minister and Foreign Minister of Sweden, shares his perspective on Europe In 60 Seconds:

What are the Russians up to against Ukraine?

We simply don't know, except the fact that they're concentrating a huge amount of military forces. And you don't do that for nothing or for fun. They are there for a purpose, to have pressure or to undertake limited to larger operations. We simply don't know. And when Putin delivered his State of the Union speech the other day, he didn't say a thing about this. They are now talking about withdrawing the forces. But let's wait and see. They have talked about withdrawing forces from Syria for a long time, but we haven't seen that as of yet.

More Show less

Australia rips up Belt & Road deal: Australia cancelled two 2018 deals signed between Victoria, Australia's wealthiest state, and the Chinese government, that committed the two sides to working together on initiatives under China's Belt and Road infrastructure development program. Foreign Minister Marise Payne said that the agreements "were adverse to our foreign relations." Similar deals between Victoria and institutions in Iran and Syria were also abandoned by the Australian government this week, under a 2020 law that allows Canberra to nullify international agreements struck at local and state level. (Australian universities say the "foreign veto bill" amounts to "significant overreach.") Meanwhile, Beijing hit back, calling the move "unreasonable and provocative," and accusing Canberra of further stoking divisions after a series of escalatory moves by both sides that have seen China-Australia relations deteriorate to their worst point in decades. Chinese investment in Australia dropped by 62 percent last year, a massive blow for Australia's export-reliant economy.

More Show less

50: The US will aim to cut its greenhouse gas emissions by 50 percent from 2005 levels by the end of the decade. The Biden administration's commitment, double the goal set by Barack Obama almost six years ago, was announced to coincide with a virtual Earth Day climate summit attended by dozens of world leaders.

More Show less

Subscribe to GZERO Media's newsletter, Signal

The GZERO World Podcast with Ian Bremmer. Listen now.


Subscribe to GZERO Media's newsletter: Signal